Addison Capital Co Has $4.87 Million Position in SPDR S&P Biotech ETF $XBI

Addison Capital Co lifted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 197.9% during the 1st quarter, Holdings Channel reports. The firm owned 38,112 shares of the exchange traded fund’s stock after purchasing an additional 25,319 shares during the quarter. Addison Capital Co’s holdings in SPDR S&P Biotech ETF were worth $4,868,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently modified their holdings of XBI. Dynamic Wealth Strategies LLC grew its holdings in SPDR S&P Biotech ETF by 3.8% during the fourth quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock worth $268,000 after purchasing an additional 80 shares during the period. Capital Investment Advisory Services LLC raised its stake in SPDR S&P Biotech ETF by 4.0% in the 4th quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock valued at $259,000 after acquiring an additional 81 shares during the period. Commerce Bank lifted its holdings in SPDR S&P Biotech ETF by 2.8% during the 4th quarter. Commerce Bank now owns 3,260 shares of the exchange traded fund’s stock valued at $397,000 after purchasing an additional 90 shares during the last quarter. Compass Ion Advisors LLC boosted its position in SPDR S&P Biotech ETF by 2.6% during the fourth quarter. Compass Ion Advisors LLC now owns 3,886 shares of the exchange traded fund’s stock worth $474,000 after purchasing an additional 97 shares during the period. Finally, Moors & Cabot Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 3.8% in the third quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock valued at $272,000 after purchasing an additional 100 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $163.87 on Wednesday. The company’s 50-day moving average is $138.55 and its 200-day moving average is $130.59. The firm has a market capitalization of $11.08 billion, a PE ratio of 11.47 and a beta of 0.82. SPDR S&P Biotech ETF has a fifty-two week low of $83.45 and a fifty-two week high of $164.35.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.